by LIFENCY media | May 23, 2024 | News
This is our promise! We’ll do it with you and for you. We’re experts in Communication, Marketing and Business Development in the Pharma, Biotech, Medtech and Life Science industries and there’s a lot we can do to support you!Market analysis, Strategy...
by LIFENCY media | Feb 6, 2024 | News
In the landscape of cancer research, abnormal epigenetic modifications emerge as crucial indicators, offering valuable insights into potential therapeutic avenues; that’s why proteins responsible for protein modification present opportunities for advancing cancer...
by LIFENCY media | Nov 27, 2023 | News
Prostate cancer ranks as the most frequent cancer among men in Switzerland between 2015 and 2019 (1). In 2020, approximately 70,000 men in Europe succumb to prostate cancer, making it the third most lethal cancer in men (2). While prostate cancer is rare in men...
by LIFENCY media | Nov 13, 2023 | Focusing on health, News
Prostate cancer ranks as the second most prevalent cancer in men and the fifth leading cause of cancer-related mortality among men in 2020. A staggering 1,414,000 new cases of prostate cancer were diagnosed, with 375,304 reported deaths in the same year. Despite these...
by LIFENCY media | Oct 23, 2023 | News
In high-income countries, the breast cancer mortality rate has decreased by 40% between 1980 and 2020, as reported by the World Health Organization (WHO) (1). Firstly, this significant decline can be attributed to advancements in screening techniques and diagnostic...
by LIFENCY media | Oct 19, 2023 | News
On October 17 was held the 8th symposium of Nephros Education organized by LIFENCY, at the Headquarters of Cassa dei Medici in the Italian Switzerland. Guided by PD Dr. Valentina Forni Ogna, Prof. Dr. med. Bruno Vogt, PhD Antonio Di Mauro, PD (Aus) Dr. med. Claudia...
